Tech Company Financing Transactions

Novocuff Funding Round

AXA Investment Managers, Avestria Ventures and Laborie Medical Technologies participated in a $26 million Series A capital raise for Novocuff. The round was announced on 7/17/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

2495 Hospital Drive 300
Mountain View, CA 94040
USA

Phone

Undisclosed

Website

www.novocuff.com

Email Address

Not Recorded

Overview

Novocuff, Inc. is a medical device company dedicated to improving pregnancy outcomes and reducing preterm births caused by PPROM and cervical shortening. Preterm birth is the leading cause of death for infants under the age of one. According to the World Health Organization (WHO), preterm birth complications were responsible for approximately 1 million deaths in 2020.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Amelia Degenkolb

        

Chief Operating Officer

Donald Lee

        

VP - Regulatory Affairs

Kathryn Wine

        

Browse more venture capital transactions:

Prev: 7/17/2024: Cloverleaf Infrastructure venture capital transaction
Next: 7/17/2024: Peak Energy venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary